输血时机与常见血管手术后围手术期心肌梗死及死亡的关系
本研究基于单一机构VQI数据库2013至2017年1154例血管手术病例,评估术中与术后输血时机对术后心肌梗死(POMI)及30天全因死亡的影响。多变量分析显示,术后输血或术中联合术后输血与POMI风险升高相关,而单纯术中输血无显著关联;输血与30天死亡无独立关联。
要点
- 术后输血及术中联合术后输血与POMI风险升高独立相关。
- 单纯术中输血未显示与POMI显著相关(OR=3.42,P=0.08)。
- 输血与30天全因死亡无独立关联,他汀使用具保护作用。
核心结论
- 术后输血及术中联合术后输血与POMI风险升高相关,单纯术中输血无显著关联。
- 调整后输血与30天全因死亡无独立关联。
研究设计与样本
- 单中心回顾性队列,审查VQI 2013至2017年六个手术/腔内模块的1154例病例。
- 纳入择期和急诊病例,所有住院手术患者常规行术后肌钙蛋白/心电图检测。
主要发现
- 总体POMI率为2%,死亡率为1%。
- POMI率因手术类型而异(P=0.04),腹股沟下旁路最高为4%,死亡率无差异(P=0.89)。
- POMI患者术中及术后平均pRBC单位数均更高(术中1.3 vs 0.3,术后1.8 vs 0.4,均P<0.01)。
- 死亡患者术中及术后平均pRBC单位数均更高(术中1.4 vs 0.3,术后2.5 vs 0.4,均P<0.01)。
- 单变量分析中高龄和冠心病与POMI相关。
关键数值与推荐
- POMI定义采用AHA第三版通用心肌梗死定义:cTnT升高和/或降低且至少一次超过99百分位,并伴缺血症状、新发缺血性心电图改变、病理性Q波、影像学新发存活心肌丢失或新发区域性室壁运动异常之一。
- 多变量分析POMI:冠心病OR=5.15(95%CI 2.00-13.24,P<0.001);术中联合术后输血 vs 未输血OR=6.20(95%CI 1.78-21.55,P<0.01);仅术后输血 vs 未输血OR=5.70(95%CI 1.81-17.94,P<0.01);仅术中输血 vs 未输血OR=3.42(95%CI 0.88-13.31,P=0.08)。
- 多变量分析死亡:年龄增加OR=1.08(95%CI 1.01-1.15,P=0.02);他汀使用OR=0.27(95%CI 0.10-0.74,P=0.01);任何术中或术后输血 vs 未输血与死亡无显著关联。
临床怎么用
- 围手术期输血时机影响术后结局,评估输血指征时应考虑术中与术后的差异。
- 对冠心病患者及需术后输血者应加强术后心肌梗死监测。
局限性
- 单中心回顾性设计,样本量有限,结论外推需谨慎。
- 仅纳入住院手术且常规检测肌钙蛋白的患者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perioperative allogenic blood transfusions, specifically packed red bloods cells (pRBC), after vascular surgery procedures are modifiable risk factors that are associated with increased cardiovascular events and 30-day mortality. The aim of this study is to evaluate the effect of transfusion timing (intraoperative vs. postoperative) on the rate of postoperative myocardial infarction (POMI) and death. METHODS: Six surgical and endovascular modules within the Vascular Quality Initiative (VQI) from 2013 to 2017 were reviewed at a single institution. Transfusion data on elective and urgent cases were abstracted and all patients who underwent inpatient procedures had routine postoperative troponin/ECG testing. The primary endpoint was POMI utilizing the American Heart Association's third universal definition for myocardial infarction. These criteria include the detection of a rise/and or fall of cTnT with at least one value above the 99th percentile and with at least one of the following 1) symptoms of acute myocardial ischemia, 2) new ischemic ECG changes, 3) development of pathological Q waves, 4) imaging evidence of new loss of viable myocardium or new regional wall motion abnormality in a pattern consistent with ischemic etiology. The secondary endpoint was 30-day all-cause mortality. Multivariable logistic regression analysis was utilized to evaluate the risk of transfusions on POMI and death. RESULTS: We identified 1,154 cases for analysis (299 abdominal aortic aneurysm [EVAR], 117 infrainguinal bypasses, 127 open abdominal aortic aneurysm [AAA], 41 suprainguinal bypasses, 168 thoracic endovascular aortic repair [TEVAR], and 402 peripheral vascular interventions). Overall, the POMI rate was 2% and mortality 1%. Rates of POMI differed by procedure type (P = 0.04), where infrainguinal bypass had the highest rate of POMI at 4%. Death rates did not vary by type of procedure (P = 0.89). Mean number of intraoperative pRBC and postoperative pRBC transfusion was higher for patients with POMI (intraop: 1.3 vs. 0.3, postop: 1.8 vs. 0.4, both P < 0.01) and death (intraop: 1.4 vs. 0.3, postop: 2.5 vs. 0.4, both P < 0.01). In addition, older age and coronary artery disease (CAD) were associated with POMI on univariate analysis. On multivariable analysis for POMI, CAD (odds ratio [OR] = 5.15, 95% confidence interval [CI] [2.00-13.24], P < 0.001), receiving both an intraoperative and postoperative transfusion (OR = 6.20, 95% CI [1.78-21.55], P < 0.01) as well as a postoperative transfusion only (OR = 5.70, 95% CI [1.81-17.94], P < 0.01) compared to no transfusion were associated with higher odds of POMI; however intraoperative transfusion only was not (OR = 3.42, 95% CI [0.88-13.31], P = 0.08). On multivariable analysis, increasing age of the patient was associated with higher odds of death (OR = 1.08, 95% CI [1.01-1.15], P = 0.02) and statin use was highly protective (OR = 0.27, 95% CI [0.10-0.74], P = 0.01), but any intraoperative or postoperative transfusion compared to no transfusion was not associated with death after adjustment. CONCLUSIONS: In our series with routine postoperative troponin screening in the inpatient setting, the use of an isolated postoperative transfusion as well as cases requiring both an intraoperative and postoperative transfusion was associated with POMI. However, isolated intraoperative transfusion was not associated with POMI, and we did not identify an association of transfusion with 30-day mortality. These data suggest that the perioperative setting of transfusions is important in its impact on postoperative outcomes and needs to be accounted for when evaluating transfusion outcomes and indications.
引用
- Heafner T, Bews K, Kalra M, et al. Transfusion Timing and Postoperative Myocardial Infarction and Death in Patients Undergoing Common Vascular Procedures. Ann Vasc Surg. 2019. PMID: 31626929. doi:10.1016/j.avsg.2019.08.090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。